Tag: orphan drug designation melanoma

Home / orphan drug designation melanoma

Categories

Melphalan is approved by FDA as a liver-directed treatment for uveal melanoma

Nov 2023: The Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) as a liver-directed treatment for adult patients with uveal me...
orphan-drug-designation-melanoma

Scan the code